Avadel Pharmaceuticals Plc ADR (AVDL)

$21.34 -0.02 (-0.09%)
Market Cap 2.08B
Revenue (ttm) 169.12M
Net Income (ttm) -48.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 130.55
Profit Margin -28.87%
Debt to Equity Ratio 0.05
Volume 1,625,380
Avg Vol 3,238,772
Day's Range N/A - N/A
Shares Out 97.66M
Stochastic %K 9%
Beta 1.26
Analysts Hold
Price Target $20.56

Company Profile

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 353 1 901 5201
Address:
10 Earlsfort Terrace, Dublin, Ireland
Its_Only_Money_369
Its_Only_Money_369 Dec. 4 at 2:05 AM
$AVDL Lets keep this thing alive! Post some nonsence
0 · Reply
Its_Only_Money_369
Its_Only_Money_369 Dec. 4 at 2:03 AM
$AVDL Fucking crickets. When you hear them they are drow out by the sound of profit. Chirp chirp alway proceeds chaching chaching. Minus some bitching and moaning
0 · Reply
Quantumup
Quantumup Dec. 1 at 1:25 PM
B.Riley⬆️ $CNTA's PT to $42 from $33 and reiterated at a Buy rating after Data Deep Dive $ALKS $TAK $AVDL $ESALY HRMY Here's what B.Riley had to say:
0 · Reply
Everest17
Everest17 Nov. 28 at 3:08 PM
$AVDL The only signal at this point is following the arbitrage firms accumulation. If we start trading above 22 there may be some chance of another offer.
1 · Reply
speed717
speed717 Nov. 27 at 8:32 PM
$AVDL If this is the it, then ALKS is stealing AVDL.
1 · Reply
Otus
Otus Nov. 26 at 7:13 PM
$AVDL so Lundback is out. For now. I don’t care. They ended up getting us a better offer. Jazz still lurking.
1 · Reply
Alex_Abou_Ezzi
Alex_Abou_Ezzi Nov. 26 at 5:05 PM
$AVDL lundbeck will not make another offer according to Bloomberg
0 · Reply
profitraider
profitraider Nov. 26 at 4:45 PM
$AVDL Told you!
1 · Reply
yekoiob
yekoiob Nov. 25 at 9:21 PM
$AVDL bidding war is over
2 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 25 at 2:58 AM
Enter: $AVDL Calls Strike Price: $25 Expiry Date: DEC 19 2025 Buy in Price: $0.30 - $0.32 Sell Price: $0.46 Profit : +54% (Turn every $1 into $1.54) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Latest News on AVDL
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting

Dec 3, 2025, 4:47 PM EST - 20 hours ago

Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting

Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting

Dec 1, 2025, 4:05 PM EST - 2 days ago

Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting

Alkermes raises offer for Avadel after Lundbeck bid

Nov 19, 2025, 6:08 AM EST - 15 days ago

Alkermes raises offer for Avadel after Lundbeck bid

ALKS

Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc

Nov 19, 2025, 6:00 AM EST - 15 days ago

Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc

ALKS

Top 2 Health Care Stocks That May Fall Off A Cliff This Month

Nov 17, 2025, 8:15 AM EST - 17 days ago

Top 2 Health Care Stocks That May Fall Off A Cliff This Month

CDTX

Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”

Nov 17, 2025, 5:45 AM EST - 17 days ago

Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal”

Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal

Nov 14, 2025, 11:37 AM EST - 20 days ago

Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal

ALKS

H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal

Nov 14, 2025, 9:40 AM EST - 20 days ago

H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal

ALKS

Alkermes reviewing options after Lundbeck makes unsolicited bid for Avadel

Nov 14, 2025, 8:17 AM EST - 20 days ago

Alkermes reviewing options after Lundbeck makes unsolicited bid for Avadel

ALKS

Avadel Receives Unsolicited Proposal from Lundbeck

Nov 14, 2025, 5:45 AM EST - 20 days ago

Avadel Receives Unsolicited Proposal from Lundbeck

ALKS

FORM 8.1(a) & (b) - Avadel Pharmaceuticals plc

Nov 5, 2025, 11:10 AM EST - 4 weeks ago

FORM 8.1(a) & (b) - Avadel Pharmaceuticals plc

Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Nov 4, 2025, 4:01 PM EST - 4 weeks ago

Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

3 Investable Laggards In An Overbought Market

Oct 28, 2025, 5:13 PM EDT - 5 weeks ago

3 Investable Laggards In An Overbought Market

BMY ETNB MRUS MTSR NVS PAGP RNA

3 Biopharma Names I Am Buying After Avadel's Buyout

Oct 26, 2025, 9:45 AM EDT - 5 weeks ago

3 Biopharma Names I Am Buying After Avadel's Buyout

Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL

Oct 22, 2025, 4:52 PM EDT - 6 weeks ago

Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL

ALKS

Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz

Oct 22, 2025, 3:18 PM EDT - 6 weeks ago

Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz

ALKS

Alkermes to acquire Avadel for up to $2.1 billion

Oct 22, 2025, 7:11 AM EDT - 6 weeks ago

Alkermes to acquire Avadel for up to $2.1 billion

ALKS

Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc

Oct 22, 2025, 7:00 AM EDT - 6 weeks ago

Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc

ALKS

Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement

Oct 22, 2025, 6:30 AM EDT - 6 weeks ago

Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Oct 13, 2025, 4:05 PM EDT - 7 weeks ago

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel: Mispriced Leader In Once-Nightly Sleep Therapies

Sep 30, 2025, 5:20 AM EDT - 2 months ago

Avadel: Mispriced Leader In Once-Nightly Sleep Therapies

Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding

Sep 16, 2025, 8:00 AM EDT - 2 months ago

Avadel Pharmaceuticals Celebrates Five Years of Driving Growth in Sleep Research Funding

Avadel: LUMRYZ Momentum And Pipeline Expansion Support Buy Rating

Sep 12, 2025, 3:29 AM EDT - 2 months ago

Avadel: LUMRYZ Momentum And Pipeline Expansion Support Buy Rating

Avadel Pharmaceuticals Plc (AVDL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 9, 2025, 4:24 PM EDT - 3 months ago

Avadel Pharmaceuticals Plc (AVDL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025

Sep 5, 2025, 8:00 AM EDT - 3 months ago

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025

Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd

Sep 3, 2025, 4:30 PM EDT - 3 months ago

Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Aug 29, 2025, 8:00 AM EDT - 3 months ago

Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

Avadel Pharmaceuticals plc (AVDL) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 1:45 AM EDT - 4 months ago

Avadel Pharmaceuticals plc (AVDL) Q2 2025 Earnings Call Transcript

Avadel (AVDL) Q2 Revenue Jumps 64%

Aug 7, 2025, 10:30 AM EDT - 4 months ago

Avadel (AVDL) Q2 Revenue Jumps 64%

Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance

Aug 7, 2025, 7:00 AM EDT - 4 months ago

Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance

Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7

Jul 31, 2025, 8:00 AM EDT - 4 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7

ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders

Jul 14, 2025, 7:00 AM EDT - 5 months ago

ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders

ASL pushes for board shakeup at Avadel over handling of sleep drug rollout

Jun 30, 2025, 9:41 AM EDT - 5 months ago

ASL pushes for board shakeup at Avadel over handling of sleep drug rollout

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

Jun 30, 2025, 7:00 AM EDT - 5 months ago

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

ASL Strategic Value Fund targets Avadel board over Lumryz drug mismanagement, WSJ reports

Jun 29, 2025, 10:30 PM EDT - 5 months ago

ASL Strategic Value Fund targets Avadel board over Lumryz drug mismanagement, WSJ reports

An investor in the narcolepsy drugmaker Avadel Pharmaceuticals plans to call for shareholders to vote out the company's entire board of directors, ratcheting up pressure

Jun 29, 2025, 9:00 PM EDT - 5 months ago

An investor in the narcolepsy drugmaker Avadel Pharmaceuticals plans to call for shareholders to vote out the company's entire board of directors, ratcheting up pressure

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Jun 5, 2025, 7:30 AM EDT - 6 months ago

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025

May 29, 2025, 4:05 PM EDT - 6 months ago

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025

Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

May 29, 2025, 8:00 AM EDT - 6 months ago

Avadel Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Avadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year'

May 15, 2025, 11:43 AM EDT - 7 months ago

Avadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year'

Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer

May 13, 2025, 4:15 PM EDT - 7 months ago

Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating Officer

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

May 13, 2025, 8:00 AM EDT - 7 months ago

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Avadel Pharmaceuticals plc (AVDL) Q1 2025 Earnings Call Transcript

May 7, 2025, 12:45 PM EDT - 7 months ago

Avadel Pharmaceuticals plc (AVDL) Q1 2025 Earnings Call Transcript

Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance

May 7, 2025, 7:00 AM EDT - 7 months ago

Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

May 6, 2025, 12:30 PM EDT - 7 months ago

Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

Apr 30, 2025, 8:00 AM EDT - 7 months ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

Apr 17, 2025, 8:00 AM EDT - 8 months ago

Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

Apr 8, 2025, 1:30 PM EDT - 8 months ago

Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 8 months ago

Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference

Its_Only_Money_369
Its_Only_Money_369 Dec. 4 at 2:05 AM
$AVDL Lets keep this thing alive! Post some nonsence
0 · Reply
Its_Only_Money_369
Its_Only_Money_369 Dec. 4 at 2:03 AM
$AVDL Fucking crickets. When you hear them they are drow out by the sound of profit. Chirp chirp alway proceeds chaching chaching. Minus some bitching and moaning
0 · Reply
Quantumup
Quantumup Dec. 1 at 1:25 PM
B.Riley⬆️ $CNTA's PT to $42 from $33 and reiterated at a Buy rating after Data Deep Dive $ALKS $TAK $AVDL $ESALY HRMY Here's what B.Riley had to say:
0 · Reply
Everest17
Everest17 Nov. 28 at 3:08 PM
$AVDL The only signal at this point is following the arbitrage firms accumulation. If we start trading above 22 there may be some chance of another offer.
1 · Reply
speed717
speed717 Nov. 27 at 8:32 PM
$AVDL If this is the it, then ALKS is stealing AVDL.
1 · Reply
Otus
Otus Nov. 26 at 7:13 PM
$AVDL so Lundback is out. For now. I don’t care. They ended up getting us a better offer. Jazz still lurking.
1 · Reply
Alex_Abou_Ezzi
Alex_Abou_Ezzi Nov. 26 at 5:05 PM
$AVDL lundbeck will not make another offer according to Bloomberg
0 · Reply
profitraider
profitraider Nov. 26 at 4:45 PM
$AVDL Told you!
1 · Reply
yekoiob
yekoiob Nov. 25 at 9:21 PM
$AVDL bidding war is over
2 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 25 at 2:58 AM
Enter: $AVDL Calls Strike Price: $25 Expiry Date: DEC 19 2025 Buy in Price: $0.30 - $0.32 Sell Price: $0.46 Profit : +54% (Turn every $1 into $1.54) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Its_Only_Money_369
Its_Only_Money_369 Nov. 24 at 10:34 PM
$AVDL If you plan to vote in favor of this lousy offer you might as well sell now while you can cash out above cash + CVR. No shame in taking profit to offset risk. Even if you walk away from 23+% in potential gains above current price. Institutions just keep adding here while risking a 6.7% loss. Why would that be? It’s because they know the potential gain is 3x the potential loss and they control enough shares to down vote the current bid.
0 · Reply
Fred_G_Sanford
Fred_G_Sanford Nov. 24 at 6:20 PM
$AVDL check the Form 8.3 just filed by Weiss Asset Management: They just added 325,000 shares at $23!!!
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 24 at 2:51 AM
Enter: $AVDL Calls Strike Price: $25 Expiry Date: DEC 19 2025 Buy in Price: $0.30 - $0.50 Sell Price: $0.66 Profit : +121% (Turn every $1 into $2.21) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 23 at 2:46 AM
Enter: $AVDL Calls Strike Price: $25 Expiry Date: DEC 19 2025 Buy in Price: $0.30 - $0.50 Sell Price: $0.45 Profit : +49% (Turn every $1 into $1.49) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 22 at 6:47 AM
Enter: $AVDL Calls Strike Price: $25 Expiry Date: DEC 19 2025 Buy in Price: $0.24 - $0.25 Sell Price: $0.54 Profit : +125% (Turn every $1 into $2.25) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
speed717
speed717 Nov. 21 at 10:00 PM
$AVDL https://atlanticwalkresearch.com/research/Avadel-Update These folks think Jazz is the likely winner when all said and done.
2 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 21 at 3:07 PM
Enter: $AVDL Calls Strike Price: $25 Expiry Date: DEC 19 2025 Buy in Price: $0.30 - $0.50 Sell Price: $0.62 Profit : +107% (Turn every $1 into $2.07) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
prismmarketview
prismmarketview Nov. 20 at 5:45 PM
(NASDAQ: $ALKS) (NASDAQ: $AVDL) #Alkermes has raised its offer to acquire #AvadelPharma to approximately $2.37 billion, increasing the offer to $22.50 per share, including $21.00 in cash plus a $1.50 contingent value right tied to FDA approval of Avadel’s narcolepsy drug Lumryz, after outbidding a rival offer from Lundbeck, with the deal expected to close in Q1 2026. https://prismmarketview.com/alkermes-raises-its-offer-to-acquire-avadel-in-2-3b-deal-focused-on-sleep-disorder-innovation/
0 · Reply
JarvisFlow
JarvisFlow Nov. 20 at 3:42 PM
Wells Fargo has adjusted their stance on Avadel Pharmaceuticals ( $AVDL ), setting the rating to Equal-Weight with a target price of 20 → 22.5.
0 · Reply
ZacksResearch
ZacksResearch Nov. 20 at 2:56 PM
$ALKS increases its offer for $AVDL — will Lundbeck up the ante? 💰 Alkermes has sweetened its bid to $22.50/share, valuing Avadel at $2.37B. With a Zacks Rank #1, this biotech battle is heating up! 🚀 Find out more about the bidding war here 👉 https://www.zacks.com/stock/news/2793522/alks-raises-its-offer-to-buy-avadel-in-response-to-lundbecks-proposal?cid=sm-stocktwits-2-2793522-body-21835&ADID=SYND_STOCKTWITS_TWEET_2_2793522_BODY_21835
0 · Reply
Rockstar201
Rockstar201 Nov. 20 at 2:32 PM
$AVDL you guys think the bidding war is done?
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 20 at 1:58 PM
Enter: $AVDL Calls Strike Price: $25 Expiry Date: DEC 19 2025 Buy in Price: $0.20 - $0.50 Sell Price: $0.45 Profit : +125% (Turn every $1 into $2.25) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply